Abstract

Photoaffinity labeling of receptors by bound agonists can provide important spatial constraints for molecular modeling of activated receptor complexes. Secretin is a 27-residue peptide hormone with a diffuse pharmacophoric domain that binds to the secretin receptor, a prototypic member of the Class B family of G protein-coupled receptors. In this work, we have developed, characterized, and applied two new photolabile probes for this receptor, with sites for covalent attachment in peptide positions 12 and 14, surrounding the previously most informative site of affinity labeling of this receptor. The [Tyr10,(BzBz)Lys12]rat secretin-27 probe covalently labeled receptor residue Val6, whereas the [Tyr10,(BzBz)Lys14]rat secretin-27 probe labeled receptor residue Pro38. When combined with previous photoaffinity labeling data, there are now seven independent sets of constraints distributed throughout the peptide and receptor amino-terminal domain that can be used together to generate a new molecular model of the ligand-occupied secretin receptor. The amino-terminal domain of this receptor presented a stable platform for peptide ligand interaction, with the amino terminus of the peptide hormone extended toward the transmembrane helix domain of the receptor. This provides clear insights into the molecular basis of natural ligand binding and supplies testable hypotheses regarding the molecular basis of activation of this receptor.

Highlights

  • A detailed understanding of the molecular basis for agonist binding to receptors and their activation can provide key insights for the rational design and refinement of receptor-active drugs

  • Characterization of [Tyr10,(BzBz)Lys12]Rat Secretin-27 and [Tyr10,(BzBz)Lys14]Rat Secretin-27—Both probes bound to the secretin receptor saturably and with high affinity

  • This was demonstrated by their ability to compete for the binding of the radioligand, 125I-[Tyr10]rat secretin-27, to the secretin receptor (Fig. 1) (secretin, Ki ϭ 12 Ϯ 3 nM; (BzBz)Lys12 probe, Ki ϭ 20 Ϯ 3.3 nM; (BzBz)Lys14 probe, Ki ϭ 31 Ϯ 4.1 nM)

Read more

Summary

EXPERIMENTAL PROCEDURES

Materials—The solid-phase oxidant, N-chlorobenzenesulfonamide (IODO-BEADs), cyanogen bromide, and m-maleimidobenzoyl-N-hydroxysulfosuccinimide ester were purchased from Pierce Chemical Co. Increasing concentrations of the (BzBz)Lys or (BzBz)Lys probe (from 0 to 1 ␮M) were incubated with a constant amount of radioligand 125I-[Tyr10]rat secretin-27, and 5 ␮g enriched CHO-SecR plasma membranes for 1 h at room temperature in KrebsRinger-HEPES (KRH) medium (25 mM HEPES, pH 7.4, 104 mM NaCl, 5 mM KCl, 1 mM KH2PO4, 1.2 mM MgSO4, 2 mM CaCl2) containing 0.01% soybean trypsin inhibitor, and 0.2% bovine serum albumin. 50 ␮g of enriched receptor-bearing plasma membranes were incubated with 0.1 nM 125I-[Tyr10,(BzBz)Lys12]rat secretin-27 or 125I-[Tyr10,(BzBz)Lys14]rat secretin-27 in the presence of increasing concentrations of secretin (from 0 to 1 ␮M) in KRH buffer in the dark for 1 h at room temperature This was photolyzed for 30 min at 4 °C in a Rayonet photochemical reactor (Southern New England Ultraviolet Company, Hamden, CT) equipped with 3500-Å lamps. The apparent molecular masses of labeled receptor fragments were determined by interpolation on a plot of the mobility of MultimarkTM protein standards (Invitrogen) versus the log values of their apparent masses

Covalently labeled residues within the secretin receptor
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call